Linked Life Data

19160239

Source:http://linkedlifedata.com/resource/pubmed/id/19160239

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-1-22
pubmed:abstractText
Epithelial ovarian cancer kills about 1700 in the UK each year. Ten to fifteen percent of all cases are diagnosed early when there is still a good chance of cure. The treatment of early stage disease involves surgery to remove disease often followed by chemotherapy. The largest clinical trials of this adjuvant therapy show an overall survival (OS) advantage with adjuvant platinum based chemotherapy but the precise role of this treatment in sub-groups of patients with differing prognoses needs to be defined.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD004706
pubmed:dateRevised
2009-7-21
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
pubmed:affiliation
Department of Obstetrics and Gynaecology, Salford Royal NHS Foundation Trust, Stott Lane, Salford, UK, M6 8HD. brett.winter-roach@srft.nhs.uk
pubmed:publicationType
Journal Article, Review, Meta-Analysis